30.10.2012 Views

Presidential Greeting - American Society for Laser Medicine and ...

Presidential Greeting - American Society for Laser Medicine and ...

Presidential Greeting - American Society for Laser Medicine and ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

patient basis <strong>for</strong> increased efficacy <strong>and</strong> safety of cutaneous laser<br />

treatments.<br />

#32<br />

A LED BASED IMAGING SYSTEM FOR<br />

OPTIMIZATION OF PHOTODYNAMIC THERAPY<br />

OF BASAL CELL CARCINOMA<br />

Rolf B. Saager, David J. Cuccia, Steven Saggesse,<br />

Kristen M. Kelly, Anthony J. Durkin<br />

Beckman <strong>Laser</strong> Institute <strong>and</strong> Medical Clinic, University of<br />

Cali<strong>for</strong>nia, Irvine, CA; Modulated Imaging, Inc., Irvine, CA<br />

Background: PDT offers the potential <strong>for</strong> enhanced treatment of<br />

BCC skin cancer without the detriments associated with current<br />

treatment methods: healthy tissue loss, scarring. Yet, PDT has<br />

still not achieved the consistent per<strong>for</strong>mance required to gain<br />

widespread clinical acceptance <strong>for</strong> treatment of skin cancer. One<br />

particular limitation is a lack of quantitative tools to per<strong>for</strong>m in<br />

vivo dosimetry that monitors the light dose during therapy. Even<br />

when dosimetry is used, lesion variability leads to treatment plans<br />

that are not optimum. To this end, we have developed a new<br />

quantitative imaging device that may enable optimized therapy.<br />

Study: Clinical imaging of BCC lesions was per<strong>for</strong>med using<br />

Spatial Frequency Domain Imaging (SFDI). SFDI can quantify<br />

spatially resolved absorption <strong>and</strong> reduced scattering coefficients.<br />

With knowledge of these properties, it is possible to address<br />

critical aspects of PDT dosimetry including: (1) therapeutic light<br />

dose within the affected tissue, (2) oxygen supply necessary to<br />

generate destructive radicals within the lesion <strong>and</strong> (3)<br />

photosensitizer distribution <strong>and</strong> uptake within the tissue. We<br />

present a device designed to address these aspects by: (1)<br />

determining the optical properties at the therapeutic wavelength,<br />

(2) deducing spatially resolved absorption values to determine<br />

blood oxygenation in the tissue microvasculature, <strong>and</strong> (3)<br />

quantifying fluorescence from the photosensitizer by<br />

compensating <strong>for</strong> native tissue properties.<br />

Results: Preliminary clinical study of nine lesions demonstrate<br />

that optical properties vary greatly both spatially (101%, 48%) <strong>for</strong><br />

absorption <strong>and</strong> reduced scattering, respectively, <strong>and</strong> from patient<br />

to patient (102%, 57%). Oxygenation maps may be generated at<br />

50-mm resolution. Fluorescence signals from the photosensitizer<br />

can be accurately converted to drug concentrations to within<br />

0.2 mg/L.<br />

Conclusion: These preliminary results indicate that this<br />

technique provides quantitative, non-invasive assessments<br />

which characterize lesions based on physiologic parameters<br />

that are inaccessible to clinicians. This technology may lead to<br />

the development of subject <strong>and</strong> lesion specific treatment<br />

strategies.<br />

#33<br />

<strong>American</strong> <strong>Society</strong> <strong>for</strong> <strong>Laser</strong> <strong>Medicine</strong> <strong>and</strong> Surgery Abstracts 11<br />

REFLECTION MODALITY CONTINUOUS-WAVE<br />

TERAHERTZ IMAGER FOR CANCER<br />

DEMARCATION<br />

Cecil Joseph, Anna Yaroslavsky, Thomas Goyette,<br />

Robert Giles<br />

University of Massachusetts, Lowell, MA<br />

Background: Continuous-wave terahertz imaging has the<br />

potential to offer a non-invasive <strong>and</strong> comparatively inexpensive<br />

technique <strong>for</strong> demarcating skin cancers. The implementation of a<br />

coherent room temperature detection scheme, which offers<br />

increased SNR, is critical to the eventual goal of implementing a<br />

continuous-wave terahertz imaging system that can delineate<br />

cancer margins.<br />

Study: The goal of this study was to construct a heterodyne<br />

receiver based imager at 1.39 THz, determine its resolution <strong>and</strong><br />

available signal-to-noise ratio, <strong>and</strong> demonstrate imaging of skin<br />

cancer specimens. CO 2 laser pumped far-infrared gas lasers were<br />

used as the terahertz sources <strong>for</strong> the experiments. A room<br />

temperature heterodyne detection scheme was designed <strong>and</strong><br />

implemented. The system was tested using resolution targets <strong>and</strong><br />

skin cancer specimens. Its resolution <strong>and</strong> signal-to-noise ratio<br />

(SNR), in reflection modality, were determined. The samples were<br />

scanned across the focal plane using a two axis motion controlled<br />

stage, <strong>and</strong> the on-axis reflection image was generated.<br />

Results: The system resolution was determined to be 0.5 mm. The<br />

SNR was determined to lie between 110 <strong>and</strong> 130 dB. Preliminary<br />

imaging data of cancer specimens show good correlation between<br />

the terahertz images <strong>and</strong> Hematoxylin & Eosin (H&E)<br />

histopathology.<br />

Conclusion: A coherent hetrodyne detection scheme significantly<br />

improves the SNR of continuous-wave terahertz imaging <strong>for</strong><br />

cancer demarcation.<br />

#34<br />

TEST METHODOLOGIES FOR ESTABLISHING<br />

SAFETY OF HOME-USE LASER BASED DEVICES<br />

David Sliney, Michail Smirnov, Stewart Wilson,<br />

Oldrich Laznicka, Oksana Bradley, Felicia Whitney,<br />

Gregory Altshuler, Ilya Yaroslavsky<br />

Fallston, MD; Palomar Medical Technologies, Burlington, MA<br />

Background: A number of home-use, laser-based devices <strong>for</strong><br />

treatment of various skin conditions either have been recently<br />

introduced to the marketplace or are in different stages of<br />

development. A common feature of these devices is the presence of<br />

a safety suite designed to enable safe operation of the device by the<br />

average person with no prior experience or training. This state of<br />

affairs highlights the need <strong>for</strong> <strong>for</strong>mulating realistic, universally<br />

accepted product safety requirements, reflected in an industrywide<br />

st<strong>and</strong>ard, such as IEC 60825. A Class 1C (conditional Class<br />

1) has been proposed <strong>and</strong> is currently under discussion by the<br />

respective technical groups. One important aspect of codifying the<br />

safety requirements <strong>for</strong> such devices is to define the most suitable<br />

testing techniques to ensure both compliance <strong>and</strong> practical safety<br />

of the device.<br />

Study: Two principal approaches to the test are considered: (1)<br />

clinical test (possibly with a mock-up device) attempting to<br />

reproduce real-life scenarios of the device use; <strong>and</strong> (2) an ex vivo<br />

<strong>and</strong>/or phantom test with a pre-<strong>for</strong>mulated set of quantitative<br />

criteria. Both types of tests have been conducted on a home-use,<br />

fractional non-ablative laser device (PaloVia, Palomar Medical<br />

Technologies, Inc.).<br />

Results: Ocular safety of the tested device has been demonstrated<br />

with both types of tests. Similarities <strong>and</strong> differences in the<br />

outcomes of the two types of testing, as well as their relative<br />

advantages <strong>and</strong> disadvantages <strong>for</strong> the purpose of laser safety<br />

st<strong>and</strong>ards, have been evaluated.<br />

Conclusion: Phantom test methodologies can be considered the<br />

preferred method to ensure compliance of the tested device with<br />

the requirements of the future per<strong>for</strong>mance st<strong>and</strong>ard.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!